Stock Events

Stock Events

BioForce Nanosciences 

$1.5000
7
+$0.14+10.29% Thursday 19:59

Statistics

Day High
1.5
Day Low
1.4
52W High
2.05
52W Low
0.18
Volume
1,150
Avg. Volume
5,359
Mkt Cap
50.28M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

2NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0
-0
-0
0
Expected EPS
0
Actual EPS
-0.0042

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-1.29MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap195.86B
Thermo Fisher Scientific offers a wide range of products for nanotechnology and life sciences research, directly competing with BioForce Nanosciences' offerings.
Illumina
ILMN
Mkt Cap28.78B
Illumina provides genomic sequencing and array-based technologies, competing in the biotechnology space with solutions that may overlap with BioForce's nanobiotechnology applications.
Agenus
AGEN
Mkt Cap139.5M
Agenus is involved in the discovery and development of immunotherapies, which may compete with BioForce Nanosciences in the development of novel nanobiotechnology-based treatments.
Biomarin Pharmaceutical
BMRN
Mkt Cap11.43B
BioMarin Pharmaceutical focuses on enzyme replacement therapies and other biotechnological products, potentially competing with BioForce's nanobiotechnology solutions.
AMGEN
AMGN
Mkt Cap196.12B
Amgen, a leader in biotechnology, develops a wide range of products that could compete with BioForce Nanosciences in the field of nanobiotechnology.
Intellia Therapeutics
NTLA
Mkt Cap1.99B
Intellia Therapeutics is a pioneer in CRISPR technology, which could be seen as a competing technology to nanobiotechnology approaches offered by BioForce.
CRISPR Therapeutics
CRSP
Mkt Cap5.25B
CRISPR Therapeutics is focused on gene editing, a cutting-edge area that competes with nanobiotechnology for therapeutic applications.
Editas Medicine
EDIT
Mkt Cap500.29M
Editas Medicine works on gene editing, directly competing with nanobiotechnology methods in the development of new therapies.
Pfizer
PFE
Mkt Cap137.76B
Pfizer, with its broad range of pharmaceutical products, competes in the healthcare sector, including areas where BioForce Nanosciences might offer nanobiotechnology solutions.
Moderna
MRNA
Mkt Cap27.09B
Moderna's focus on mRNA technology for therapeutics and vaccines represents a competing approach to BioForce's nanobiotechnology applications in medicine.

About

BioForce Nanosciences Holdings, Inc. (BFNH) specializes in providing natural vitamins, minerals, and a variety of other nutritional supplements, along with powders and beverages, intended for individuals across all age demographics. The firm also operates in the private label market, collaborating with both distributors and production partners. Under its BioForce Eclipse brand, BFNH's dietary supplements reach consumers through a broad network of retailers, including general merchandise stores, sporting goods shops, grocery chains, and large mass merchandisers. Additionally, the company facilitates sales directly via its online presence and telemarketing campaigns. Its corporate base is situated in Virginia Beach, Virginia.
Show more...
CEO
Mr. Richard Kaiser
Employees
3
Country
United States
ISIN
US09064C2061

Listings

OTC Link
US
BFNH

0 Comments

Share your thoughts

FAQ

What is BioForce Nanosciences stock price today?▼
The current price of BFNH is $1.50 USD — it has increased by +10.29% in the past 24 hours. Watch BioForce Nanosciences stock price performance more closely on the chart.
What is BioForce Nanosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange BioForce Nanosciences stocks are traded under the ticker BFNH.
Is BioForce Nanosciences stock price growing?▼
BFNH stock has fallen by -3.23% compared to the previous week, the month change is a -16.2% fall, over the last year BioForce Nanosciences has showed a +100% increase.
What is BioForce Nanosciences market cap?▼
Today BioForce Nanosciences has the market capitalization of 50.28M
What were BioForce Nanosciences earnings last quarter?▼
BFNH earnings for the last quarter are -0 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is BioForce Nanosciences revenue for the last year?▼
BioForce Nanosciences revenue for the last year amounts to 0 USD.
What is BioForce Nanosciences net income for the last year?▼
BFNH net income for the last year is -1.29M USD.
How many employees does BioForce Nanosciences have?▼
As of July 18, 2026, the company has 3 employees.
In which sector is BioForce Nanosciences located?▼
BioForce Nanosciences operates in the Essentials sector.
When did BioForce Nanosciences complete a stock split?▼
The last stock split for BioForce Nanosciences was on February 28, 2020 with a ratio of 1:5.
Where is BioForce Nanosciences headquartered?▼
BioForce Nanosciences is headquartered in Virginia Beach, United States.